BIOMAT Database Logo BIOMAT Database Logo

Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH Receptor. 2003

Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Department of Medicinal Chemistry, Neurocrine Biosciences, Inc., 10555 Science Center Drive, San Diego, CA 92121, USA. ftucci@neurocrine.com

A new class of small molecule GnRH antagonists, the 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils, was designed and a novel stereoselective synthesis for these compounds was developed. The stereochemical integrities of key intermediates (S)-6 and (R)-6 were confirmed by a combination of X-ray crystallography and chiral HPLC determinations. SAR studies were performed, which allowed the identification of derivatives (R)-9f, (R)-9h and (R)-12 as potent hGnRH antagonists (K(i)=20 nM).

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011966 Receptors, LHRH Receptors with a 6-kDa protein on the surfaces of cells that secrete LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE, usually in the adenohypophysis. LUTEINIZING HORMONE-RELEASING HORMONE binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE by the cell. These receptors are also found in rat gonads. INHIBINS prevent the binding of GnRH to its receptors. GnRH Receptors,Gonadoliberin Receptors,Gonadorelin Receptors,Gonadotropin Releasing-Hormone Receptors,LHFSHRH Receptors,LHRH Receptors,Luliberin Receptors,Receptors, GnRH,Receptors, Gonadoliberin,Receptors, Gonadorelin,Receptors, Luliberin,Follicle Stimulating Hormone-Releasing Hormone Receptors,GnRH Receptor,Gonadorelin Receptor,Gonadotropin-Releasing Hormone Receptor,LHRH Receptor,Luteinizing Hormone Releasing Hormone Receptors,Luteinizing Hormone Releasing-Hormone Receptor,Receptor, LHRH,Receptors, Gonadotropin Releasing-Hormone,Receptors, LHFSHRH,Follicle Stimulating Hormone Releasing Hormone Receptors,Gonadotropin Releasing Hormone Receptor,Gonadotropin Releasing Hormone Receptors,Hormone Receptor, Gonadotropin-Releasing,Luteinizing Hormone Releasing Hormone Receptor,Receptor, GnRH,Receptor, Gonadorelin,Receptor, Gonadotropin-Releasing Hormone,Receptors, Gonadotropin Releasing Hormone,Releasing-Hormone Receptors, Gonadotropin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)- 5-[2-[(3-substituted)-1-azetidinyl]ethyl]-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptor.
November 2002, Journal of medicinal chemistry,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes.
January 2001, Bioorganic & medicinal chemistry letters,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists.
October 1993, Journal of medicinal chemistry,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
2-Halogenoethylamines as potential folic acid antagonists. I. Synthesis and biological activity of ethyl-N-[1-(2-amino-4-hydroxy-6-methyl-5-pyrimidyl)-3-(2-chloro)-propyl]-p-aminobenzoate.
May 1965, Journal of pharmaceutical sciences,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
November 2007, Bioorganic & medicinal chemistry,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil.
April 1997, Journal of medicinal chemistry,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.
December 2009, Bioorganic & medicinal chemistry letters,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
July 1991, Journal of medicinal chemistry,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Structure-activity relationships of N2-aryl-3-(isoxazolylsulfamoyl)-2-thiophenecarboxamides as selective endothelin receptor-A antagonists.
May 1997, Journal of medicinal chemistry,
Fabio C Tucci, and Yun-Fei Zhu, and Zhiqiang Guo, and Timothy D Gross, and Patrick J Connors, and R Scott Struthers, and Greg J Reinhart, and John Saunders, and Chen Chen
Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonists.
November 2012, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!